Drug Shortage Report for M-QUETIAPINE FUMARATE XR
| Report ID | 233189 |
| Drug Identification Number | 02527960 |
| Brand name | M-QUETIAPINE FUMARATE XR |
| Common or Proper name | M-QUETIAPINE |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | QUETIAPINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-06-25 |
| Estimated end date | |
| Actual end date | 2025-09-22 |
| Shortage status | Resolved |
| Updated date | 2025-10-01 |
| Company comments | Quetiapine est discontinuée. Il ne reviendra pas. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-09-03 | French | Compare |
| v3 | 2024-09-03 | English | Compare |
| v2 | 2024-07-17 | French | Compare |
| v1 | 2024-07-17 | English | Compare |